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Patient dose calculation software 
Radiation protection 
A B S T R A C T   
Purpose: In interventional cardiology, patients may be exposed to high doses to the skin resulting in skin burns 
following single or multiple procedures. Reviewing and analysing available software (online or offline) may help 
medical physicists assessing the maximum skin dose to the patient together with the dose distribution during (or 
after) these procedures. 
Method and results: Capabilities and accuracy of available software were analysed through an extensive bibli-
ography search and contacts with both vendor and authors. Their markedly differed among developers. 
In total, 22 software were identified and reviewed according to their algorithms and their capabilities. Special 
attention was dedicated to their main features and limitations of interest for the intended clinical use. 
While the accuracy of the 12 software products validated with measurements on phantoms was acceptable 
(within ± 25%), the agreement was poor for the two products validated on patients (within ± 43% and ± 76%, 
respectively). In addition, no software has been validated on angiographic units from all manufacturers, though 
several software developers claimed vendor-independent transportability. Only one software allows for multiple 
procedures dose calculation. 
Conclusion: Large differences among vendors made it clear that work remains to be done before an accurate and 
reliable skin dose mapping is available for all patients.   
1. Introduction 
Since the 1980 s, the introduction of more sophisticated endovas-
cular devices in interventional cardiology (IC) allowed more complex 
procedures to be performed, thus potentially increasing the exposure to 
the patients, resulting in tissue reactions (e.g. skin burns) following 
single or multiple procedures. 
As a consequence, reports on radiation-induced patient skin injuries 
started to emerge, highlighting the need for optimised and personalised 
patient dosimetry. Patient dosimetry, a necessity that has further 
strengthened, due to the increasing in the number of IC procedures over 
the years. 
Assessing the Maximum Skin Dose (MSD) to the patient during (or 
after) those procedures together with 2D dose distribution is, as rec-
ommended by the International Commission on Radiation Protection 
(ICRP) Committee 3 [1], essential from patient radiation protection 
point of view. 
Until recently, measurements using passive dosimeters were the only 
way to assess patient’s MSD accurately. However, as these measure-
ments are tedious to perform and expensive, they could not be 
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performed routinely at clinics and a more convenient means to estimate 
MSD was needed [2]. 
Automated online and offline Skin Dose Calculation (SDC) solutions 
have therefore been developed. Online software use live data streaming 
from the angiographic systems to calculate skin doses directly during the 
procedures, while offline solutions use data stored in the Radiation Dose 
Structured Report (RDSR) to compute skin exposure post-procedure (see 
Table 1). 
Currently, most vendors have implemented some form of skin dose 
calculations in their angiographic systems: from simple solutions only 
computing MSD values, to more advanced software solutions calculating 
a 2D or 3D distribution of the skin dose. 
Offline SDC software solutions have also been developed in research- 
based institutions or for commercial purposes, both as stand-alone 
products or integrated into the Dose Archiving and Communication 
Systems (DACS). 
Within this context, the European project VERIDIC (Validation and 
Estimation of Radiation skIn Dose in Interventional Cardiology) was 
started in February 2018 [3]. 
One of the main objectives of the project was to review and validate 
existing SDC software products since medical physicists should be able 
to reliably assess patient dose in Interventional Cardiology while 
providing cath labs with dosimetry report in case of overexposed 
patients. 
Large variety of dose software make such a task difficult and a critical 
evaluation of available products is essential from patient radiation 
protection point of view. 
This paper focuses on the review of the software products. 
2. Material and methods 
Since significant dose differences can occur depending on whether a 
given parameter is accurately considered in the MSD calculation, 
available SDC software solutions were collected and analysed according 
to their calculation algorithms and their specific features [4,5]. 
Physical parameters used for calculation of the MSD (tube voltage, 
filtration, beam orientation, table position, backscatter factor (B), table 
attenuation, air kerma-to-skin dose conversion coefficient) were also 
assessed. 
A critical analysis of software was carried out by considering the 
following properties:  
• their calculation algorithms;  
• the physical factors considered in the calculation of the MSD 
estimates;  
• the modelling of patient’s body shape;  
• their capabilities of providing users with a 2D or 3D-dose distribution 
(graphical dose representations were qualitatively compared). 
In order to gather all this information, the four major manufacturers 
of angiographic systems as well as all other developers included in 
Table 1 were contacted by mail. Some of them provided documents (not 
only published papers) and technical reports detailing the way the MSD 
were assessed and the modelling of the patient body shape. Technical 
information associated with SDC software developed by independent 
companies was also obtained through a literature review and/or per-
sonal contacts with the developers. It was not possible to obtain infor-
mation about the calculation details for all considered systems. This was 
due to a lack of answers. Research laboratories were not contacted 
because sufficient data was provided in their published papers. 
Both online and offline software (i.e. whether software provides the 
user with the MSD and possibly the dose distribution during or after the 
procedure, respectively) developed after 2000 were considered. Older 
software that was not available anymore like the program of den Boer 
et al. [5] was not considered. All products not using the RDSR as a source 
of information, thus missing the information about the fluoroscopy part 
of the procedures were also omitted. 
3. Results 
3.1. Software products 
A total of 22 software products were identified. Most of them (18 out 
of 22) were “offline” systems. From a radiation protection point of view, 
“online” systems are preferable since they allow optimization of the 
MSD during the procedure. 
Table 1 lists the software that were collected until the end of the 
VERIDIC project. The product name, manufacturer of the software if 
relevant and publication references describing the features of the soft-
ware are listed in Table 1. Where no reference was available, direct 
contact with the authors provided documentation about the software. 
Among the listed MSD software, only 4 were online, namely Dose, 
MCGPU, DoseMap and DTS, out of 16 contacted software designers 13 
provided an answer, while Philips, Siemens and SECTRA did not respond 
to the survey. Six non-commercial designers were not directly contacted 
since their publications were self-explanatory. 
3.2. Dose calculation 
The MSD calculation formula used by different manufacturers and 
non-commercial developers is presented below. 
There is a clear agreement among the developers on how to assess 
the MSD value. 
Except for MC-GPU and FDEIR, which model the particle transport 
via Monte Carlo (MC) simulations, all listed software use a formula 
comparable to the methodology proposed by Jones and Pasciak [30] for 
systems compliant with IEC standards. 
The displayed air kerma at the reference point (Ka,r) [31] is corrected 
to account for the calibration of the Ka,r against quality control mea-
surements, the table and mattress attenuation, the contribution of the 
backscattered radiation, the distance between the reference point and 
the actual patient entrance point and the conversion of air kerma to dose 
in tissue as follows: 





× fskin [1] 
Table 1 
List of available Maximum Skin Dose calculation software.  
Software Name Company name References 
Dose Map GE healthcare [7,8,9,10] 
Dosewatch GE healthcare [11,12] 
DTS CANON Medical Systems [13,14,15] 
em.dose ESPRIMED [16,17] 
Radimetrics BAYER NA 
RDM MEDSQUARE [18] 
DOSE QAELUM NA 
UF-RIPSA Non-commercial [19,20,21] 
MCAR Non-commercial [22,23] 
FDEIR Non-commercial [24] 
MCGPU Non-commercial [25] 
TeamPlay SIEMENS Healthineers NA 
Dosewise PHILIPS NA 
Dosetrack SECTRA NA 
Nexodose BRACCO [26,27] 
Dose monitor PACSHEALTH NA 
Dosem INFINITT NA 
OpenSkin Open Source NA 
PySkinDose Open Source [28] 
SkinCare Open Source [29] 
CAATSDOSE CAATS NA 
DIDO Hospital San Carlos Madrid Madrid NA 
MCAR: Mayo Clinic Arizona&Rochester; CAATS:Centre d’Assurance de qualité 
des Applications Technologiques dans le domaine de la Santé; DTS: Dose 
Tracking Software; DIDO : Dicom Dose ; NA : Not Available. 
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Where : 
CF is the calibration factor or the ratio between the measured and the 
displayed, Ka,r, 
AC is the attenuation coefficient of the table and the mattress, 
B is the backscatter factor, 
dref is the distance between the X-ray focal spot and the reference 
point, 
dperp is the distance between the X-ray focal spot and the patient 
entrance reference point (PERP) 
fskin is the ratio of the mass-energy-absorption coefficients from skin- 
to-air. 
It is worth noting that the correction factor for the attenuation effect 
of the table is actually the transmission factor. 
In the definition of their calculation formula, Jones and Pasciak [30] 
did not include the scatter radiation from adjacent field. Neither does 
any of the reviewed software; however, it has a very limited influence 
[20]. 
3.3. Output of SDC software 
As it can be seen (Table 2) outputs of SDC software can be qualita-
tively compared. 
Almost all are color-coded according to dose level values. Use of 3D 
phantoms allows an easier visual interpretation of results, some can even 
be turned around and some are online or nearly online. 
4. Discussion 
4.1. Comparison of software 
Table 3 details the information concerning parameters used in the 
SDC calculation given in formula [1] and allows the comparison be-
tween different developers. 
a) CF: some developers did not specify the value used in their sys-
tems, did not define it clearly or did not use it (OpenSkin, CAATSDOSE). 
However, this is of crucial importance owing to the permissive Eu-
ropean acceptability criterion which states that the accuracy of the 
displayed Ka,r1 shall not be higher than 35% above 100 mGy. 
The CF values can be fixed (DoseWatch) or varying according to the 
beam energies considered (UF-RIPSA), to both acquisition and fluoro-
scopic imaging modes (DTS, MCAR) or to any exposure conditions [5]. 
In any case, currently the RDSR (36) provides the user with a single 
CF. Such a single CF is probably not sufficient for an accurate calculation 
of skin dose, since it has to take into account the calibration of displayed 
Ka,r at different energies, which can vary. For example, heavier filtered 
beams (0.1–0.2 mm Cu) exhibit a higher dependence as compared to less 
filtered beams. For those beam qualities the dependence is in the range 
of 10%–15% for 70–90 kV energies [38]. 
b) AC: many options are possible and different ones are chosen by 
each provider, like data taken from the literature or a fixed value. 
As a general rule, table/mattress attenuations are either based on 
results of physical measurements or on mathematical simulations (UF- 
RIPSA,) for different X-ray beam projection angulations. 
Attenuation values are often defined according to X-ray beam quality 
used for a given procedure and considering presence or absence of the 
table in the beam. Ideally, the beam angulation should also be consid-
ered, since it affects the path travelled by the X-rays in the table and 
mattress (Dose Map, DoseWatch). 
From measurements on a table with a 5-cm thick mattress, Bordier 
et al. [6] observed about 10% difference in the beam intensity 
comparing Postero-Anterior (PA) and Right Anterior Oblique (RAO) 40◦
projections. In agreement with this, DeLorenzo et al. [4] observed a 
decrease of 6% for RAO 40◦ projection. It should be noted that, in 
addition to the mattress attenuation, Dose Map accounts explicitly for 
the contribution of the scatter originating from the mattress. 
c) B: some variations in the choice of B values were found (see 
Table 2). One software used a fixed value per procedure (MCAR), 
whereas most software (DOSE, RDM, em.Dose, PySkinDose, OpenSkin, 
DIDO) used tabulated values or interpolation of those values selected 
according to technical parameters (possibly beam quality (kV and 
filtration), field size and phantom thickness [39]). 
The most frequently used B source is clearly the simulation work of 
Benmakhlouf et al. [35,36]. In this work, B of a 15 cm-thick water 
phantom were calculated for numerous beam qualities representative of 
modern angiography equipment with tube voltage from 50 to 150 kV for 
5 different field sizes [35]. Those Bs were later [35,36] extended to 
phantom thicknesses between 5 and 40 cm. It is obvious that the choice 
of B has a strong influence on the accuracy of MSD calculation since the 
MSD is directly proportional to it, as illustrated in Table 3. Not many 
software use alternative approaches to estimate B. 
DoseMap uses the irradiated area as unique input in a logarithmic 
model developed for a specific angiographic unit. Measurements on the 
very same x-ray equipment showed that this approach would not cause 
more than 4% dose uncertainty. 
Two software (DoseWatch and UF-RIPSA) refer to [32], which covers 
limited beam qualities compared to the extensive database of Ben-
makhlouf et al. [35,36]. The more complete method (FDEIR MC-GPU), 
based on Monte Carlo simulations, inherently takes the contribution of 
the scattered photons into consideration.  
a) Air-to-Tissue conversion factor (f-skin): most software use a single 
value of 1.06 while others do not provide any information.  
b) Patient model: concerning the anatomy of the patient, the simplest 
approaches rely on elliptical or super-elliptical models (scalable or 
not with real patient height and weight) or just consider the patient 
as a 2D flat surface. Other approaches use anthropomorphic phan-
toms voxelized from the CT images of a standard patient, such as the 
ICRP phantom [34] or from the digital human modelling project, or 
hybrid phantoms from the University of Florida - National Cancer 
Institute library [40,41]. 
In order to illustrate how the use of either fixed or variable B, 
attenuation coefficients and patient diameters may influence SDC re-
sults, Table 3 compares two examples of cardiac procedures concerning 
two different average patient diameters of 20 and 35 cm respectively. 
For the whole procedure and for each patient thickness, three tube 
voltage ranges were considered for the assessment of the total skin dose 
according to equation above while B as well as table attenuation co-
efficients were alternatively considered as fixed or variable. Therefore, 
the same IC procedure resulted in two cumulative skin dose values, the 
difference of which is detailed in Table 3. 
As expected, the influence of the correction of the B is greater for the 
thicker patient, higher kV and heavily filtered X-ray beams, thus 
resulting in a dose difference between both methods reaching 20%. 
Conversely, the influence of such a correction is significantly smaller for 
thinner patient, the dose difference between both methods in this case 
being around 6%. 
Knowing that an interventional cardiology procedure may result in a 
skin dose level of a few Gy, the consideration of physical parameters 
such as B and/or AC, as realistically as possible, plays an essential role. 
The thicker the patient, the greater the dose difference was. 
According to the information presented in Table 2, each considered 
software may allow an accurate MSD calculation if integrating either 
physical, calibration measurements or input on patient’s characteristics. 
Nevertheless, the most interesting point of the software review for the 
final user is the comparison of their major key features, limitations and 
accuracy (Table 4). This is a difficult exercise owing to the 
1 Actually, the European acceptability criterion refers to the Kerma-Area 
product, but a similar accuracy can be extrapolated to the Ka,r,. An identical 
criterion is also proposed by the IEC (2010). 




. Examples of SDC software outputs.  
Dose Map DoseWatch DTS 
Radimetrics RDM DOSE 
em.dose UF-RIPSA MCAR 
FDEIR OpenSkin SkinCare 
(continued on next page) 
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Table 2 (continued ) 
Dose Map DoseWatch DTS 
CAATSDOSE PySkinDose DIDO 3D 
DIDO 2D   
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incompleteness of available information about the capabilities of certain 
software products. 
Most of the software are “offline” systems and extract the data 
necessary to the MSD calculations from the dose report or from RDSR; 
only four software (Dose Map and DTS, system specific; Dose and 
MCGPU, streaming) provide “online” dose mapping, collecting data 
directly from the modality. 
Unfortunately RDSR information content and position are not 
standardised among the vendors and even for a given manufacturer, 
DICOM tag can differ, thus not facilitating the extraction of the data. 
Obviously, from a radiation protection point of view, “online” sys-
tems are preferable since they allow monitoring and optimisation of the 
MSD during the procedure. However, collecting data from the modality 
is cumbersome and system-specific. While the RDSR, though not always 
available as streaming data during the procedure, should follow specific 
DICOM standards and, hence, should be accessible to all software de-
velopers [37]. 
It appeared that most software use ray tracing techniques to identify 
the irradiated area, which should allow them to account correctly for the 
contribution of overlapping beams to the MSD. Since ray tracing algo-
rithms have become widely accessible thanks to the increasing avail-
ability of powerful graphics workstations in the scientific and computing 
communities, it is reasonable to believe that all the listed software sys-
tems use such algorithms, even if such information was not available for 
all. 
The most frequent shortcoming of the reviewed systems is surely the 
lack of clarity on the CF and AC used for the MSD calculation: sometimes 
the method applied was not clearly defined and uncertainties were not 
available; some developers used a single CF without any beam quality 
correction; others used a CF and/or a AC measured or simulated for one 
single system, which limits the transportability of the system. The same 
comments apply to the backscatter factors. 
Very few developers (DOSE, DTS, MCAR) mentioned the shape and 
the uniformity of the irradiation field, owing to the presence of wedge 
filters or the heel effect as a source of uncertainty. It is unclear whether 
other developers accounted for those. Since that information is not 
available in the RDSR, that issue was unlikely to have been considered. 
Furthermore, none of the reviewed software products reports the un-
certainty associated with the MSD estimation. 
Output data completeness and dose reporting interactivity of each 
system are very dependent on developer’s capability or willingness to 
display relevant dosimetric information: MSD, skin dose map, dose map 
resolution, angular distribution of different parameters like Pka, Ka,r, 
number of events etc. 
Graphical representation of skin dose mapping Johnson et al. [19] as 
well as the intrinsic map resolution is also varying from one developer to 
another. Images representing the mapping of skin doses for the different 
software are also given in Table 5. These representations range from 
Table 3 
: Comparison of CF, AC, B, f-skin and patient model by developers.  
Software 
Name 
Ka,r calibration factor(CF) Attenuation coefficient of 
table and mattress (AC) 
Backscatter factor(B) f-skin Patient model 
Dose Map Unknown value Per event, second order 
polynomial model vs kV. 
Per event, 
logarithmic model B 
= a ln(area) + b. 
Unknown value Elliptical phantoms 
Dosewatch 2 values per equipment Per event, set by user and 
corrected for beam angulation 
per equipment. 
Per event [32] Per event [33] Anthropomorphic phantoms [34] 
DTS Per event, from calibration 
measurements. 
Per event, from calibration 
measurements and corrected 
for beam angulation. 
Per event, from 
calibration 
measurements 
Single value [1.06] CAESER database patient modelling 
em.dose Single value set by user Per event, set by user for 
different beam qualities. 
Per event [35] Single value [1.06] Elliptical phantoms 
Radimetrics Single value set by user Per event, calculated, based 
on table definition (thickness, 
material) and Half Value 
Layer. 
Per event [35] Calculated based on 
lookup tables and 
depending on beam’s and 
Half Value Layer 
Average population phantom or if height 
and weight or height and diameter 
available in RDSR calculated with scaled 
to height phantom. 
RDM Single value set by user Per event, set by user (PA) and 
corrected for beam 
angulation. 
Per event [35] Per event [34] Rectangular parallelepiped with two half- 
cylinders on the side 
DOSE Unknown value Per event, set by user and 
corrected for beam angulation 
and kV. 
Per event [35] Unknown value Elliptical phantoms 
UF-RIPSA Per event, from Kerma Area 
Product calibration curves 
set by user. 
Per event, from Monte Carlo 
simulated coefficients for one 
system. 
Per event [32] Unknown; per event University of Florida hybrid phantom 
library 
MCAR Single value set by user Single value set by user Single value set by 
user 
Not implemented Mathematical phantoms (2011); likely 
elliptical phantoms (2013) 
FDEIR Unknown value NA NA NA Voxelised CT phantom 
MC-GPU Unknown value NA NA NA Voxelised phantom 
OpenSkin Not implemented From measurements on one 
system 
Per event [35] Per event [35] Rectangular parallelepiped with two half- 
cylinders on the side 
PySkinDose Per event, from calibration 
measurements. 
Per event, from measurements 
on one system. 
Per event [35] Per event [35] No patient representation 
SkinCare Per event, single value set 
by user or from 
measurements for specific 
system. 
Per event, single value set by 
user or from measurements 
for specific system. 
Per event [35] Per event [35] 3D human models with different sizes, 
heights and gender 
CAATSDOSE From calibration Quality 
Control measurements 
Single value set by user Per event [35,36] Single value [1.06] Flat surface 
DIDO From calibration at 
standard conditions (80 kV, 
low filtration) 
Per event, (kV, filtration, 
angle) Measured in Canon 
Infinix 8000. 
Per event Single value [1.06] - plane- elliptic and anthropomorphic 
phantoms 
kV: kilovoltage; ICRU: International Commission on Radiation Units & Measurements ; ICRP: International Commission on Radiological Protection ; PA: Posterio- 
Anterior ; RDSR: Radiation Dose Structured Report; NA: Not Applicable 
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sophisticated colour codes on a 3D representation of the patient to a 
simple grey-scale 2D distribution on a flat representation of the patient’s 
back, possibly including a gauge of maximum skin dose difficult to 
modify. This, again, underlines the lack of harmonisation of the content 
display, and makes an overlay of procedures performed on different 
systems or in different centres quite difficult. That is why the availability 
of a minimal set of parameters and the possibility to revert back more 
complex representations to a harmonized 2D mapping should be 
advised. 
Capability of the software to be used with any kind of x-ray equip-
ment is an essential point. 
It is frequently claimed by independent, commercial software de-
velopers (em.dose, Radimetrics, RDM, DOSE, DoseWatch), while soft-
ware from angiographic system manufacturers, such as DTS from Canon 
and Dose Map from GE, are system-specific. The same information for 
non-commercial software was usually not available. Open access soft-
ware are able to handle RDSR of most angiographic systems at the 
present time. 
4.2. Comparison of software key features 
Four different classes of technical characteristics were considered in 
order to compare the listed SDC software:  
a) the system adopted to identify irradiated area : most software used a 
ray tracing algorithm to identify the irradiated area (DTS, RDM, 
DOSE, UF-RIPSA, MCAR and Openskin)  
b) skin dose map resolution : patient skin surface is mostly represented 
as a dense mesh the spatial resolution of which can vary according to 
the software developer from 0.5 to 2.5 cm2 (DoseMap, DoseWatch, 
RDM, Radimetrics, CAATSDOSE and MCAR)  
c) potential for organ dosimetry : only a few software using Monte 
Carlo simulation to assess maximum skin dose may allow for other 
organ dose evaluation (FDEIR, MC-GPU, UF-RIPSA)  
d) phantom model: several types of phantoms are used to simulate 
patient morphology. From a simplistic 2D representation (DoseMap, 
RDM, DOSE, CAATSDOSE) to a cylindrical or elliptical representa-
tion (DoseMap, Openskin, em.dose, DOSE), scalable 3D anthropo-
morphic phantom (DoseWatch, Radimetrics), a library 3D 
anthropomorphic model (DTS), a library of 3D anthropomorphic 
voxelized phantom (UF-RIPSA). The choice of the appropriate 
phantom is an important parameter regarding the MSD calculation 
accuracy. It is worth noting that SkinCare software, in addition to 3D 
human models, included a set of PMMA slabs for calibration of MSD. 
4.3. Benchmarking of SDC software 
All systems but two (Open Skin and PySkin Dose) have been vali-
dated in clinical set-ups against measurements with thermoluminescent 
dosimeters (TLD), optically stimulated luminescence (OSL) dosimeters, 
radio-photoluminescence (RPL) dosimeters or, most frequently, gaf-
chromic films. 
Most validation measurements were performed using phantoms 
(Polymethylmethacrylate (PMMA) slabs, water, tissue equivalent or 
anthropomorphic); only 3 systems (Dose Map, DoseWatch and em.dose) 
were validated on patients. 
For phantom measurements, the calculated MSD agreed with the 
measurements within ± 25%. For patient measurements, the agreement 
was poorer or similar to the phantom values and the MSD agreed with 
Table 4 
: Comparison of SDC with fixed or variable parameters.   
Parameter Fixed  Variable  
Patient diameter: 20 cm   < 80 kV 80 to 110 kV greater than 110 kV  
Half Value Layer: 3.12 mm Al @ 80 kV B  1.4 1.3 1.4  1.45  
AC  0.8 0.75 0.8  0.9  
Skin Dose AC + B (Fixed)  7.12 (Gy) % difference between both SDC results: 6   
Skin Dose AC + B (Variable)  7.56 (Gy)   
Patient diameter: 35 cm B  1.4 1.5 1.57  1.6 
Half Value Layer 5.94 mm Al @ 80 kV AC  0.8 0.75 0.8  0.9  
Skin Dose AC + B (Fixed)  11.03 (Gy) % difference between both SDC results: 19   
Skin Dose AC + B (Variable)  13.31 (Gy)   
B: Backscatter factor; AC: Attenuation coefficient; SDC: Skin Dose Calculation 
Table 5 
: Benchmarking of SDC software.  
Software Name Validated on System used for validation MSD agreement Reference 
Dose Map Water and anthropomorphic phantom GE Innova IGS 530 and 540 (-8.6% ; 25%)(-14% ; 13%)(-53% ; 76%) [7][8][9] 
Patient (<1%) [10] 
DoseWatch Patient GE Innova IGS 530 9.5% with em.dose8.3% with DoseMap [12] 
DTS PMMA phantom Toshiba/Canon Infinix-i Bi-plane ±10% [42] 
em.dose PMMA phantom Siemens Artis ZEE (-36% ; 53%) [16] 
Anthropomorphic phantom (-6.3% ; 25%) [17] 
Patient (-43% ; 34%) 
RDM PMMA phantom GE Innova IGS 540Siemens Artis Zee (-19% ; 21%)(-24% ; 3%) [18] 
DOSE Water phantom Few Siemens Artis and Philips Allura 7% [43] 
UF-RIPSA PMMA phantom Siemens Artis ZEE (-14% ; − 6.2%) [20,21] 
MCAR PMMA phantom Siemens Artis ZEE (-9% ; 5.9%) [22,23] 
FDEIR Water phantom GE Innova 4100-IQ RPL dosimeters and PHITS ± 6% [24] 
MC-GPU PMMA phantom  TLDs : ± 6% Penelope Code : ±1%  
PySkinDose  Philips Allura Siemens Artis ZEE In progress [28] 
SkinCare PMMA phantom Patient Siemens Artis (-37% ; 43.9%) [29] 
CAATSDOSE Patient GE Innova ± 25% with DoseMap  
DIDO Work in progress Canon InfiniX 2D version: ion chamber 5%.  
PMMA: Polymethylmethacrylate; RPL: Radiophotoluminescent; TLDs: radiothermoluminescent dosimetrers; PHITS: Particules and heavy ion transport code system 
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the measurements within ± 76% for Dose Map, within ± 43% for em. 
dose and within ± 25% in a more recent publication. SkinCare software 
results agreed within ± 44%. It should be noted that MC-GPU and FDEIR 
were only validated for limited beam projections (PA and RAO 30◦, 
respectively), whereas some systems were validated for several pro-
jections or sequences of projections. 
Few systems were also validated against MC simulations (FDEIR, 
MC-GPU, UF-RIPSA) and agreed within ± 6%. DoseWatch was 
compared against Dose Map and em.dose during real procedures and 
showed agreement within 10% on average. 
It is worth noting that no software was actually physically validated 
on angiographic units from all vendors, though several software de-
velopers claimed vendor-independent transportability. 
Software were usually validated on one, maximum two, types of 
angiographic units. 
These wide discrepancies in the validation methods highlight the 
need for extended physical validation of the software. 
4.4. Limitation of SDC software 
A variety of limitations were found among the reviewed SDC 
software: 
a) Parameter Accuracy : UF-RIPSA software specifically provides a 
family of AC simulated trough Monte Carlo calculation as well as CF but 
only for one system. 
DTS calibration procedure is vendor-related, making its assessment 
by the local medical physicist difficult. The RDM software also makes 
MSD calculations using single CF and AC values without any correction 
for the beam quality while this parameter plays an important role on 
dose calculation accuracy (see table 3). 
In many cases the way CF and/or AC are determined and taken into 
account in MSD assessment is:  
• unknown (FDEIR, MC-GPU, OpenSkin)  
• unclear (DoseMap, DOSE)  
• kept constant for all beam projections (DoseWatch, RDM, UF-RIPSA, 
OpenSkin, PySkinDose, CAATSDOSE) 
b) Software Portability : some packages (DoseMap, DTS) are vendor- 
specific which restricts their use to a larger scale of existing equipment. 
Many are not compatible with all four major vendors (Radimetrics, 
RDM, em.dose, DoseWatch, DIDO…). DIDO also has to be used with 
DOLQA dose manager system (developed in Hospital Clínico San Carlos, 
Madrid), but could be exported to other systems. 
c) Patient Skin Representation Accuracy : A simplistic 2D patient 
representation is used by a few software designers (CAATSDOSE, Dos-
eMap, em.dose, RDM, OpenSkin, MCAR) thus limiting an easy visual 
interpretation of MSD results. Others (DoseWatch, DTS, UF-RIPSA, 
MCAR, SkinCare, DIDO 3D) use a 3D representation and allow to 
modify shape according to patient real height and weight. 
d) Results Accuracy : Reliability of MSD results is dependent on pa-
tient’s position on the table. The position of the patient is not stan-
dardized so difficult to record. 
e) Software Validation : Validation of software is not routinely or 
homogenously performed which makes MSD results comparison diffi-
cult (see Table 5). There is a need for a standardized benchmarking 
protocol in order to make the validation process accessible to all and to 
allow easy comparison of results. 
f) Integral Dose Assessment : All software but one (CAATSDOSE) do 
not allow for summation of dose mapping for multiple procedures per-
formed on the same patient. 
5. Conclusion 
This paper identified 22 dose calculation software products and 
reviewed key features and limitations for each of them, provided the 
information was available. 
Among the analysed systems, only four were online, although they 
are considered as the most efficient for optimizing radiation protection 
of the patients. Currently, only two online systems are still maintained 
and upgraded routinely. 
As for the offline systems, only 14 out of 20 could be analysed in 
detail due to lack of information for 6 systems. From the 14 analyses, 2 
skin dose calculation used Monte-Carlo simulations and 12 used the 
same formula for analytical calculations. Major differences were found, 
both in use of factors embedded in the formula and in the modelling of 
the body of the patient. 
Only 2 software allows for summation of dose mapping for multiple 
procedures performed on the same patient, while only one can do it for 
procedures performed on different machines. 
Although some results claimed by developers were pretty accurate, 
large differences among vendors made it clear that work remains to be 
done before an accurate and reliable skin dose mapping is available for 
all patients. 
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F, Siiskonen T, Knežević Ž. Patient maximum skin dose in interventional 




[4] Berry KE. Estimating Fluoroscopic Peak Skin Dose Using Manual Calculations: 
Health Phys 2018;114(6):649–53. 
[5] DeLorenzo MC, Yang K, Li X, Liu B. Comprehensive evaluation of broad-beam 
transmission of patient supports from three fluoroscopy-guided interventional 
systems. Med. Phys. 2018;45(4):1425–32. 
[6] den Boer A, de Feijter PJ, Serruys PW, Roelandt Jos RTC. Real-Time Quantification 
and Display of Skin Radiation During Coronary Angiography and Intervention. 
Circulation 2001;104(15):1779–84. 
[7] Bordier C, Klausz R, Desponds L. Accuracy of a dose map method assessed in 
clinical and anthropomorphic phantom situations using Gafchromic films. Radiat 
Prot Dosimetry 2015;165(1-4):244–9. 
[8] Bordier C, Klausz R, Desponds L. Patient dose map indications on interventional X- 
ray systems and validation with Gafchromic XR-RV3 film. Radiat Prot Dosimetry 
2015;163(3):306–18. 
[9] Nilsson Althén J, Sandborg M. Verification of indicated skin entrance air kerma for 
Cardiac X-Ray-guided Intervention Using Gafchromic film. Radiat Prot Dosimetry 
2016;169(1-4):245–8. 
[10] Didier R, Bourhis D, Oueslati C, Nasr B, Le Ven F, Noël A, Jobic Y, Damien P, Pene- 
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